A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
Open Access
- 15 January 2023
- journal article
- letter
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 6 (3) , 115-116
Abstract
A 37‐year‐old woman developed persistent low‐grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine. She noticed coin‐sized hair loss on day +22, and it became widespread within 1 week. The patient's hair mostly recovered leaving only one oval bald patch on day +310 with topical corticosteroid therapy alone.Keywords
This publication has 7 references indexed in Scilit:
- New‐onset systemic lupus erythematosus after ChAdOX1 nCoV‐19 and alopecia areata after BNT162b2 vaccination against SARS‐CoV‐2Dermatologic Therapy, 2022
- Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222)JAAD Case Reports, 2022
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair lossDermatologic Therapy, 2022
- Alopecia areata following COVID‐19 vaccination: vaccine‐induced autoimmunity?International Journal of Dermatology, 2022
- Alopecia areata after COVID-19 vaccinationClinical and Experimental Vaccine Research, 2022
- Alopecia areata after SARS-CoV-2 vaccinationJAAD Case Reports, 2021
- Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in ItalyJournal of Cosmetic Dermatology, 2021